We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Siemens Healthineers - Laboratory Diagnostics

Download Mobile App




Global Hemostasis Analyzers Market Driven by Increasing Awareness of Blood Disorder Conditions

By LabMedica International staff writers
Posted on 09 Feb 2023
Print article
Image: The global hemostasis analyzers market is expected to reach close to USD 6 billion in 2026 (Photo courtesy of Pexels)
Image: The global hemostasis analyzers market is expected to reach close to USD 6 billion in 2026 (Photo courtesy of Pexels)

Hemostasis analyzers are devices used for measuring clotting mechanisms of hemostasis in order to detect clotting deficiencies. The body’s natural ability to quickly stop bleeding in order to stop serious blood loss is known as hemostasis. Hemostasis analyzers are used to perform tests such as APTT tests, D dimer tests, platelet function tests, fibrinogen tests, prothrombin time tests, and other tests using optical technology, mechanical technology, electrochemical technology, and other technologies. Within hemostasis analyzers, the main products are clinical laboratory analyzers, point-of-care testing analyzers, and consumables. Clinical laboratory analyzers are used to calculate the concentration of certain substances in various samples. The various end users of hemostasis analyzers are hospitals and clinics, diagnostic centers, research and development organizations and ambulatory surgical centers, among others.

The global hemostasis analyzers market is expected to reach USD 5.97 billion in 2026, driven by the increasing awareness of blood disorder conditions such as Hemophilia and Von Willebrand disease (vWD) which are genetic disorders and not well known to people. This results in late diagnosis of blood disorders and affects patient outcomes. The increasing awareness is expected to improve the diagnosis rate of blood disorders, thereby driving the demand for hemostasis analyzers. However, recalls of defective devices could act as a restraint to the growth of the hemostasis analyzers market. These are the latest findings of ReportLinker (Lyon, France), a market research solution provider.

The hemostasis analyzers market consists of sales of complete blood count (CBC), factor v assay, fibrinogen level, prothrombin time (PT or PT-INR), platelet count, and thrombin time. Manufacturers of hemostasis analyzers are developing portable, handheld hemostasis analyzers which are convenient for carrying anywhere and are small enough to fit in a person's palm. These portable hemostasis analyzers offer a quicker and easier testing process, and facilitate independent analysis of results. Geographically, North America dominated the global hemostasis analyzers market in 2022 with the largest share, followed by Western Europe with the second-largest share.

Related Links:
ReportLinker 

Platinum Supplier
Xylazine Immunoassay Test
Xylazine ELISA
Gold Supplier
Automated Staining Unit
RAL Stainer
New
HPLC Gradient Pump
Q-CLC 340
New
Semi Auto Biochemistry Analyzer
TurboStat

Print article
GLOBETECH PUBLISHING LLC

Channels

Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more

Molecular Diagnostics

view channel
Image: A CRISPR technology-based diagnostic test detects MPXV in clinical samples with acute precision (Photo courtesy of 123RF)

Powerful Diagnostic Tool Accurately Detects Monkeypox Virus Faster Than Any Method

At present, testing for the monkeypox virus (MPXV) is done mainly in centralized labs, and it can take days to get results due to location and logistical issues. Now, researchers have leveraged cutting-edge... Read more

Hematology

view channel
Image: The US FDA has cleared HemoScreen point of care CBC for direct capillary sampling (Photo courtesy of PixCell Medical)

Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

The world’s only 5-part differential Complete Blood Count (CBC) analyzer that is FDA-cleared, CE-marked, and TGA-approved for point-of-care use has now been granted FDA 510(k) clearance for direct capillary... Read more

Immunology

view channel
Image: Immune cells present long before infection predict flu symptoms (Photo courtesy of Shutterstock.com)

Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms

For decades, if not centuries, scientists have struggled to solve the mystery of why certain individuals fall ill to infections while others remain unaffected. In an impressive development, researchers... Read more

Microbiology

view channel
Image: The rapid diagnostic test could pinpoint the correct antibiotic for infection treatment in under an hour (Photo courtesy of Microplate Dx)

Point-of-Care Device to Reduce Antibiotic Susceptibility Testing Time from Days to Minutes

Antimicrobial resistance (AMR) is a significant global health issue, currently leading to over 1.27 million deaths worldwide each year. By 2050, AMR could be causing up to 10 million deaths annually, surpassing... Read more

Pathology

view channel
Image: The Tasso+ device has received CE Mark certification (Photo courtesy of Tasso)

Groundbreaking Blood Lancing Device Obtains Microliter Capillary Whole Blood Samples Painlessly

A convenient, virtually pain-free blood lancet that collects whole liquid blood samples has received CE Mark designation, making the patient-centric, high-volume blood collection solution available in... Read more

Technology

view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.